跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
neuroprotective agent
首页
药物
neuroprotective agent
neuroprotective agent
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
TREATMENT OF OCULAR DISEASES USING ENDOTHELIN RECEPTOR ANTAGONISTS
EP 4050997 A4
申请人: PERFUSE THERAPEUTICS INC
优先权: 2019
CN
EP
US
WO
11 件公开
COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE
EP 4037696 A4
申请人: CHILDRENS MEDICAL CENTER
优先权: 2019
CN
EP
US
WO
4 件公开
Diterpenes from the fruiting body of Antrodia camphorata and pharmaceutical compositions thereof
US 7601854 B2
申请人: KANG JIAN BIOTECH CORP LTD
优先权: 2006
US
4 件公开
COMPOSITIONS FOR TREATMENT OF OCULAR DISEASES
EP 4100406 A4
申请人: PERFUSE THERAPEUTICS INC
优先权: 2020
CN
EP
US
3 件公开
NEUROPROTECTIVE AGENTS FOR USE IN THE TREATMENT OF OPTIC NEUROPATHIES
EP 4440555 A4
申请人: UNIV LELAND STANFORD JUNIOR
优先权: 2021
EP
US
WO
3 件公开
NEUROPROTECTIVE AGENT
EP 4793271 A1
申请人: NAT CENTER NEUROLOGY & PSYCHIATRY
优先权: 2023
CN
EP
WO
3 件公开
WO 2025243724 A1
申请人: NAT CENTER NEUROLOGY & PSYCHIATRY
优先权: 2024
WO
PARAXANTHINE-BASED BIOACTIVE COMPOSITION AND METHOD OF USE THEREOF
US 2023115966 A1
申请人: INGENIOUS INGREDIENTS LP
优先权: 2021
US
WO
3 件公开
Use of tellurium containing compounds as nerve protecting agents
US 7629382 B2
申请人: BIOMAS LTD
优先权: 2005
US
3 件公开
Methods and compositions for preserving the viability of photoreceptor cells
US 7592330 B2
申请人: MASSACHUSETTS EYE & EAR INFIRM
优先权: 2006
US
3 件公开
US 9549895 B2
申请人: NAKAZAWA TORU
优先权: 2007
US
2 件公开
USE OF NEUTROPHIL INHIBITORY FACTOR IN COMBINATION WITH OTHER THROMBOLYTIC OR NEUROPROTECTIVE DRUGS FOR TREATING PATHOPHYSIOLOGICAL CONDITIONS INVOLVING NEUTROPHILS
WO 0232446 A3
申请人: PFIZER LTD
优先权: 2000
US
WO
2 件公开
第 1 / 10 页
上一页
下一页
药物
反馈